Shanghai Chicmax Cosmetic Co., Ltd. is a prominent player in the cosmetics and personal care industry, specializing in the development, production, and distribution of skincare, beauty, and personal grooming products. As a corporation rooted in innovation and quality, Shanghai Chicmax is renowned for its diverse portfolio of brands that cater to a wide range of consumer preferences and needs. Its offerings span facial care, body care, sun protection, and makeup, reflecting the company's commitment to enhancing beauty and personal well-being. Notable for its advanced manufacturing processes and a keen focus on research and development, Chicmax maintains a competitive edge by integrating the latest scientific insights and consumer trends into its product lines. Operating primarily within the rapidly growing Chinese beauty market, the company also plays a crucial role in the region's economy, influencing industry standards and driving market expansion. With a strategic vision and robust market presence, Shanghai Chicmax Cosmetic Co., Ltd. continues to shape the future of the beauty industry in China and beyond.
Industry
Household & Personal Products
Consumer Defensive sector · China
Stories
Structural patterns identified in Shanghai Chicmax Cosmetic Co., Ltd.
No stories identified yet.
Key Metrics
Market Capitalization
34.66BHKD
NormalMar 18, 2026
Trailing P/E
23.66HKD
NormalMar 18, 2026
Revenue (TTM)
8.40BHKD
NormalMar 18, 2026
Forward Yield
1.79%
Annual Rate
HKD 1.09
Paid semi-annual
Payout Ratio
65.6%
Moderate
Loading dividend history...
Track Record
Frequency
Semi-Annual
Upcoming
Ex-Dividend Date
Sep 29, 2025
Valuation9
Market Capitalization
34.66BHKD
NormalMar 18, 2026
Enterprise Value
28.07BHKD
NormalMar 18, 2026
Trailing P/E
23.66HKD
Coordination
Placeholder CorpCoordination
Example HoldingsCoordination
Sample IncCoordination
Profit Margin
12.22%
Normal
Mar 18, 2026
Beta
0.1780HKD
NormalMar 18, 2026
52-Week Change
23.98HKD
ExtremeMar 18, 2026
Forward Annual Dividend Yield
1.79%
NormalMar 18, 2026
Normal
Mar 18, 2026
Forward P/E
15.47HKD
NormalMar 18, 2026
PEG Ratio
15.47HKD
ExtremeMar 18, 2026
Price to Sales (TTM)
3.29HKD
NormalMar 18, 2026
Price to Book (MRQ)
8.89HKD
NormalMar 18, 2026
Enterprise to Revenue
3.34HKD
NormalMar 18, 2026
Enterprise to EBITDA
30.90HKD
AboveNormalMar 18, 2026
Profitability & Growth58
Profit Margin
12.22%
NormalMar 18, 2026
Operating Margin
11.87%
NormalMar 18, 2026
Return on Assets (TTM)
0.1222HKD
NormalMar 18, 2026
Return on Equity (TTM)
0.4088HKD
NormalMar 18, 2026
Revenue (TTM)
8.40BHKD
NormalMar 18, 2026
Revenue per Share (TTM)
18.59HKD
NormalMar 18, 2026
Quarterly Revenue Growth
0.1730HKD
NormalMar 18, 2026
Gross Profit (TTM)
6.23BHKD
NormalMar 18, 2026
EBITDA
1.07BHKD
ExtremeMar 18, 2026
Net Income (TTM)
1.03BHKD
NormalMar 18, 2026
Quarterly Earnings Growth (YoY)
0.3060HKD
NormalMar 18, 2026
Operating Cash Flow (TTM)
811.85MHKD
NormalMar 18, 2026
Levered Free Cash Flow (TTM)
-221.15MHKD
NormalMar 18, 2026
Forward Annual Dividend Rate
1.09HKD
NormalMar 18, 2026
Forward Annual Dividend Yield
1.79%
NormalMar 18, 2026
Trailing Annual Dividend Rate
1.35HKD
NormalMar 18, 2026
Trailing Annual Dividend Yield
2.21%
NormalMar 18, 2026
Payout Ratio
0.6559HKD
NormalMar 18, 2026
Minority Interest (Equity)
43.48M
NormalFY2024 · Dec 31, 2024
Revenue
6.79B
NormalFY2024 · Dec 31, 2024
Cost of Goods Sold
1.68B
NormalFY2024 · Dec 31, 2024
Gross Profit
5.11B
NormalFY2024 · Dec 31, 2024
Operating Income
921.85M
NormalFY2024 · Dec 31, 2024
Pre-tax Income
926.97M
NormalFY2024 · Dec 31, 2024
Income Tax Expense
123.67M
NormalFY2024 · Dec 31, 2024
Net Income
803.30M
NormalFY2024 · Dec 31, 2024
EBIT
933.04M
NormalFY2024 · Dec 31, 2024
ebitda-income
1.07B
NormalFY2024 · Dec 31, 2024
Research & Development
179.87M
NormalFY2024 · Dec 31, 2024
Selling, General & Administrative
4.19B
NormalFY2024 · Dec 31, 2024
Non-operating Interest Income
6.13M
NormalFY2024 · Dec 31, 2024
Non-operating Interest Expense
6.07M
NormalFY2024 · Dec 31, 2024
EPS (Basic)
1.96
NormalFY2024 · Dec 31, 2024
EPS (Diluted)
1.96
NormalFY2024 · Dec 31, 2024
Basic Shares Outstanding
397.99MShares
NormalFY2024 · Dec 31, 2024
Diluted Shares Outstanding
397.99MShares
NormalFY2024 · Dec 31, 2024
Net Income from Continuing Operations
926.97M
NormalFY2024 · Dec 31, 2024
Minority Interests (P&L)
-22.09M
NormalFY2024 · Dec 31, 2024
Preferred Stock Dividends
0.00
NormalFY2024 · Dec 31, 2024
Operating Cash Flow
603.73M
NormalFY2024 · Dec 31, 2024
Free Cash Flow
304.38M
NormalFY2024 · Dec 31, 2024
Cash & Cash Equivalents (End of Period)
459.45M
NormalFY2024 · Dec 31, 2024
Net Income (CF Statement)
926.97M
NormalFY2024 · Dec 31, 2024
Stock-based Compensation
6.55M
NormalFY2024 · Dec 31, 2024
Other Non-cash Items
-56.00K
NormalFY2024 · Dec 31, 2024
Change in Accounts Receivable (CF)
-111.11M
NormalFY2024 · Dec 31, 2024
Change in Other Assets/Liabilities
-218.62M
NormalFY2024 · Dec 31, 2024
Capital Expenditures
-224.58M
NormalFY2024 · Dec 31, 2024
Net Intangibles (CF)
-8.05M
NormalFY2024 · Dec 31, 2024
Net Acquisitions
-47.43M
NormalFY2024 · Dec 31, 2024
Purchase of Investments
-296.75M
NormalFY2024 · Dec 31, 2024
Sale of Investments
389.77M
NormalFY2024 · Dec 31, 2024
Net Investing Cash Flow
-178.99M
NormalFY2024 · Dec 31, 2024
Long-term Debt Issuance
220.00M
NormalFY2024 · Dec 31, 2024
Long-term Debt Payments
-259.93M
NormalFY2024 · Dec 31, 2024
Common Dividends Paid
-522.04M
NormalFY2024 · Dec 31, 2024
Other Financing Charges
10.45M
NormalFY2024 · Dec 31, 2024
Net Financing Cash Flow
-551.52M
NormalFY2024 · Dec 31, 2024
Financial Strength26
Shares Outstanding
398.07MShares
NormalMar 18, 2026
Float Shares
76.27MHKD
NormalMar 18, 2026
% Held by Insiders
0.6304HKD
NormalMar 18, 2026
% Held by Institutions
0.1356HKD
NormalMar 18, 2026
Total Cash (MRQ)
907.85MHKD
NormalMar 18, 2026
Total Cash per Share (MRQ)
2.01HKD
NormalMar 18, 2026
Total Debt (MRQ)
341.43MHKD
NormalMar 18, 2026
Total Debt to Equity (MRQ)
12.01HKD
AboveNormalMar 18, 2026
Current Ratio (MRQ)
1.94HKD
NormalMar 18, 2026
Book Value per Share (MRQ)
6.87HKD
NormalMar 18, 2026
Total Assets
3.60B
NormalFY2024 · Dec 31, 2024
Total Current Assets
2.47B
NormalFY2024 · Dec 31, 2024
Total Liabilities
1.36B
NormalFY2024 · Dec 31, 2024
Total Non-current Assets
1.13B
NormalFY2024 · Dec 31, 2024
Total Non-current Liabilities
19.96M
NormalFY2024 · Dec 31, 2024
Total Current Liabilities
1.34B
NormalFY2024 · Dec 31, 2024
Cash & Cash Equivalents
459.45M
NormalFY2024 · Dec 31, 2024
Other Short-term Investments
273.26M
NormalFY2024 · Dec 31, 2024
Accounts Receivable
439.09M
NormalFY2024 · Dec 31, 2024
Inventory
690.64M
NormalFY2024 · Dec 31, 2024
Accounts Payable
638.41M
NormalFY2024 · Dec 31, 2024
Short-term Debt
102.22M
NormalFY2024 · Dec 31, 2024
Long-term Debt
9.45M
NormalFY2024 · Dec 31, 2024
Common Stock (Book)
398.02M
NormalFY2024 · Dec 31, 2024
Retained Earnings
545.58M
NormalFY2024 · Dec 31, 2024
Total Shareholders' Equity
2.23B
NormalFY2024 · Dec 31, 2024
Market & Technical9
52-Week Low
40.05HKD
NormalMar 18, 2026
52-Week High
104.80HKD
NormalMar 18, 2026
52-Week Change
23.98HKD
ExtremeMar 18, 2026
Beta
0.1780HKD
NormalMar 18, 2026
50-Day MA
66.09HKD
NormalMar 18, 2026
200-Day MA
80.51HKD
NormalMar 18, 2026
Avg 10-Day Volume
1.19MHKD
NormalMar 18, 2026
Avg 30-Day Volume
1.15MHKD
NormalMar 18, 2026
Diluted EPS (TTM)
2.58HKD
NormalMar 18, 2026
Screen for dividend patterns
Find other stocks with similar dividend characteristics in the screener.